STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q3 2023 Earnings Call Transcript

As you have seen in the past few quarters since the deployment of this model, the expansion was slower in terms of expansion in a number of clinics and was also limited in the returns per clinic in the sales or revenue per device per clinic. So that’s my compare and contrast between the two of them. I think moving forward, we tend to be successful with deploying this as a reimbursable procedure because we have all of the support mechanism to give the suite of services and provide these services to the clinics and to the patients.

Jeffrey Cohen: Okay, Dolev, perfect. Thank you very much for taking the questions. Appreciate it.

Dolev Rafaeli: Absolutely. Thank you.

Operator: Thank you. [Operator Instructions] All right. I see no further questions at this time. I’d now like to turn the floor back over to management for any closing remarks.

Dolev Rafaeli: Thank you, operator, and everyone, for your time and investment in STRATA Skin Sciences. We look forward to update you on our progress in the next quarterly call.

Operator: This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation.